Treatment of heparin-induced thrombocytopenia with fondaparinux

Anticoagulation of patients with heparin-induced thrombocytopenia (HIT) may be limited by cross-reaction of HIT antibodies with danaparoid and generation of antibodies during therapy with lepirudin. We used fondaparinux to treat 6 patients with a history of HIT with thromboembolism and 2 patients wi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Harenberg, Job (VerfasserIn) , Jörg, Ingrid (VerfasserIn) , Fenyvesi, Tivadar (VerfasserIn)
Dokumenttyp: Article (Journal) Editorial
Sprache:Englisch
Veröffentlicht: 2004
In: Haematologica
Year: 2004, Jahrgang: 89, Heft: 8, Pages: 1017-1018
ISSN:1592-8721
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://haematologica.org/article/view/3180
Volltext
Verfasserangaben:J. Harenberg, I. Jorg, T. Fenyvesi
Beschreibung
Zusammenfassung:Anticoagulation of patients with heparin-induced thrombocytopenia (HIT) may be limited by cross-reaction of HIT antibodies with danaparoid and generation of antibodies during therapy with lepirudin. We used fondaparinux to treat 6 patients with a history of HIT with thromboembolism and 2 patients with thrombocytopenia during low-molecular-weight heparin administration.
Beschreibung:Gesehen am 21.04.2022
Beschreibung:Online Resource
ISSN:1592-8721